Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

Share Price is delayed by 15 minutes
Get Live Data
0.0215    0.00 (0.00%)
Bid:
0.003
Ask:
0.04
Spread: 0.037 (1,233.333%)
Market Cap: $3.14m
ALF Live PriceLast checked at - London Stock Exchange

Intraday Alternative Liq Share Chart

Compliance with Model Code

3 Oct 2017 13:41

RNS Number : 5776S
Alternative Liquidity Fund Limited
03 October 2017
 

 

 

 

STOCK EXCHANGE ANNOUNCEMENT

 

For immediate release 3 October 2017

 

ALTERNATIVE LIQUIDITY FUND LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 60552)

 

 

COMPLIANCE WITH THE MARKET ABUSE REGULATION

 

Alternative Liquidity Fund Limited (the "Company") wishes to notify the market that the closed period of the Company in relation to its final results for the period ended 30 June 2017 commenced on 1 October 2017 and is anticipated to end following the release of those results on 31 October 2017.

 

The Company confirms that all inside information (as defined in the EU Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory information service. Accordingly, in the absence of any new undisclosed inside information arising, the Company is not prohibited from dealing in its own securities during this closed period.

 

 

Enquiries

Tim Gardner

Tel. +44 20 3551 2917

Email. tg@waranacap.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CMCLLFVFITLVIID
Date   Source Headline
29th Apr 20264:32 pmRNSAnnual Report and Audited Financial Statements
5th Mar 20264:00 pmRNSNet Asset Value and Factsheet
19th Dec 20251:30 pmRNSNet Asset Value and Factsheet
11th Dec 20255:15 pmRNSResult of AGM
21st Nov 20254:14 pmRNSNotice of AGM
9th Oct 20254:30 pmRNSNet Asset Value, Fund Update and Factsheet
22nd Sep 20255:20 pmRNSReceipt of Funds and Return of Capital
10th Jul 20259:00 amRNSShareholder Update
8th Jul 202511:05 amRNSHolding(s) in Company
8th Jul 202511:04 amRNSHolding(s) in Company
3rd Jul 20259:45 amRNSPortfolio Update
24th Jun 20254:00 pmRNSHolding(s) in Company
19th Jun 20259:00 amRNSNet Asset Value and Factsheet
5th Jun 20253:03 pmRNSHolding(s) in Company
5th Jun 202510:00 amRNSHolding(s) in Company
23rd May 20253:04 pmRNSHolding(s) in Company
13th May 20253:37 pmRNSHolding(s) in Company
21st Mar 20254:50 pmRNSHalf-year Report
17th Mar 20259:30 amRNSNet Asset Value and Factsheet
3rd Feb 20257:00 amRNSAmalgamation of Administrator
9th Dec 20241:00 pmRNSPortfolio Update
4th Dec 20242:49 pmRNSResult of AGM
2nd Dec 20245:00 pmRNSNet Asset Value and Factsheet
22nd Nov 20244:16 pmRNSNotice of AGM
24th Oct 20247:00 amRNSAnnual Financial Report
25th Sep 202412:00 pmRNSNet Asset Value and Factsheet
30th Aug 20247:00 amRNSTotal Voting Rights
16th Aug 202411:44 amRNSCancellation of Shares
26th Jul 20249:36 amRNSPortfolio Update
21st Jun 20241:22 pmRNSFinal Net Asset Value & Factsheet
20th Mar 20241:55 pmRNSHalf-year Report
27th Feb 20242:00 pmRNSNet Asset Value and Factsheet
6th Dec 20232:03 pmRNSResult of AGM
27th Nov 20232:00 pmRNSNet Asset Value and Factsheet
21st Nov 20231:45 pmRNSNotice of AGM
26th Oct 20238:36 amRNSAnnual Financial Report
29th Sep 20237:00 amRNSTotal Voting Rights
8th Sep 20237:00 amRNSCancellation of Shares
30th Aug 20232:00 pmRNSPortfolio Update
29th Aug 202310:30 amRNSNet Asset Value and Factsheet
19th Jun 202311:30 amRNSFinal Net Asset Value & Factsheet
23rd Mar 20237:00 amRNSHalf-year Report
20th Mar 20239:05 amRNSSecond Price Monitoring Extn
20th Mar 20239:00 amRNSPrice Monitoring Extension
23rd Feb 202312:00 pmRNSNet Asset Value and Factsheet
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
14th Feb 202311:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.